Inoue, T.; Sekito, S.; Kageyama, T.; Sugino, Y.; Sasaki, T.
Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment. Cancers 2023, 15, 2662.
https://doi.org/10.3390/cancers15092662
AMA Style
Inoue T, Sekito S, Kageyama T, Sugino Y, Sasaki T.
Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment. Cancers. 2023; 15(9):2662.
https://doi.org/10.3390/cancers15092662
Chicago/Turabian Style
Inoue, Takahiro, Sho Sekito, Takumi Kageyama, Yusuke Sugino, and Takeshi Sasaki.
2023. "Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment" Cancers 15, no. 9: 2662.
https://doi.org/10.3390/cancers15092662
APA Style
Inoue, T., Sekito, S., Kageyama, T., Sugino, Y., & Sasaki, T.
(2023). Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment. Cancers, 15(9), 2662.
https://doi.org/10.3390/cancers15092662